Alvotech Joins Nasdaq Biotechnology Index, Boosting Industry Presence
Alvotech ( (ALVO) ) just unveiled an announcement.
Merck downgraded to Market Perform from Outperform at BMO Capital
BMO Capital downgraded Merck (MRK) to Market Perform from Outperform with a price target of $105, down from $136. The firm cites Merck’s ...